Anúncio
Anúncio

ENSC

ENSC logo

Ensysce Biosciences, Inc. Common Stock

1.01
USD
Patrocinado
-0.05
-4.81%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

1.00

0.00
-0.40%

Relatórios de Lucros ENSC

Rácio de surpresa positiva

ENSC separação 11 de 16 últimas estimativas.

69%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$510.00K
/
-$1.28
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.45%
/
-0.78%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-60.89%
/
-55.86%

Ensysce Biosciences, Inc. Common Stock earnings per share and revenue

On 14 de nov. de 2025, ENSC reported earnings of -1.29 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -46.21% surprise. Revenue reached 493.00 mil, compared to an expected 714.00 mil, with a -30.95% difference. The market reacted with a -4.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -1.28 USD, with revenue projected to reach 510.00 mil USD, implying an diminuir of -0.78% EPS, and aumentar of 3.45% in Revenue from the last quarter.
FAQ
For Q3 2025, Ensysce Biosciences, Inc. Common Stock reported EPS of -$1.29, missing estimates by -46.21%, and revenue of $493.00K, -30.95% below expectations.
The stock price moved down -4.85%, changed from $2.06 before the earnings release to $1.96 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 3 analistas, Ensysce Biosciences, Inc. Common Stock is expected to report EPS of -$1.28 and revenue of $510.00K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio